Short- and long-term racing performance of Standardbred pacers and trotters after early surgical intervention for tarsal osteochondrosis

Determinants of joint effusion in tarsocrural osteochondrosis of yearling Standardbred horses

Tarsocrural osteochondrosis (OCD) is a developmental orthopedic disease commonly affecting young Standardbreds, with different fragment localization and size. Clinically, it is characterized by variable synovial effusion in the absence of lameness, whose determinants are ill-defined. We hypothesized that localization and physical characteristics of the osteochondral fragments like dimensions, multifragmentation, and instability influence joint effusion and correlate with synovial markers of cartilage degradation and inflammation. Clinical data, synovial fluid and intact osteochondral fragments were collected from 79 Standardbred horses, aged between 12 and 18 months, operated for tarsocrural OCD. The severity of tarsocrural joint effusion was assessed semi-quantitatively. The osteochondral fragment site was defined radiographically at the distal intermediate ridge of the tibia (DIRT), medial malleolus (MM) of the tibia, and/or lateral trochlear ridge (LTR) of the talus. Size, stability, and arthroscopic appearance (unique or multi-fragmented aspect) of the fragments were determined intra-operatively. Synovial concentrations of C-terminal cross-linked telopeptides of type II collagen (CTX-II), leukotriene B4 (LTB4), and prostaglandin E2 (PGE2) were quantified. Tarsocrural synovial effusion was significantly affected by localization and stability of the fragments, with MM-located and unstable fragments being associated with highest joint effusion. Concentrations of CTX-II, LTB4, and PGE2 positively correlated with the severity of synovial effusion. This study underlines characteristics of the osteochondral fragments determining higher synovial effusion in OCD-affected tarsocrural joints and suggests both inflammation and extra-cellular matrix degradation are active processes in OCD pathology.

Impact of periarticular osteophytes of the distal tarsus diagnosed in nonlame yearling Standardbred horses on racing performance

OBJECTIVE

The aim of this study was to identify the radiographic prevalence of periarticular osteophytes of the distal tarsus in nonlame yearling Standardbred horses, and to evaluate its potential impact on race performance.

STUDY DESIGN

Cross-sectional cohort study.

ANIMALS

Client-owned yearling Standardbred horses (n = 416).

METHODS

Bilateral tarsal radiographs were available from all horses for review. Osteophytes were measured on radiographs using clinical visualization software and categorized by size. Racing records were obtained from the United States Trotting Association. Regression analysis was used to determine associations between presence or size of periarticular osteophytes and performance parameters with sex and gait covariates.

RESULTS

Of 416 Standardbred yearlings without clinical lameness, 113 (27.1%) had distal tarsal periarticular osteophytes. Regression analyses revealed few associations between the presence of periarticular osteophytes and performance parameters. Affected horses had fewer starts at 4 years of age (incident rate ratio [IRR] 0.92, p = .01) and fewer lifetime starts (IRR 0.95, p = .003), but the effect size was small. Within the affected group, osteophyte size was only associated with number of starts at 3 (IRR 0.67, p < .0001). Sex and gait affected many performance parameters.

CONCLUSION

The prevalence of distal tarsal periarticular osteophytes was similar to that in other breeds. Periarticular osteophytes of the distal tarsus appeared to be a largely incidental finding in nonlame yearling Standardbreds intended for harness racing.

CLINICAL SIGNIFICANCE

Distal tarsal periarticular osteophytes in young, nonlame Standardbred horses should affect racing potential only minimally. This is in contrast to reports from other disciplines.

Plantar osteochondral fragments in young Standardbreds are associated with minimal joint inflammation at the time of surgical removal

BACKGROUND

Plantar osteochondral fragments (POF) are common but their effect on joint health of young Standardbreds in race training is largely unknown.

OBJECTIVES

Evaluate the inflammatory effects of POF in metatarsophalangeal joints of young Standardbreds as a step towards developing evidence-based recommendations for surgical removal.

STUDY DESIGN

Cohort study.

METHODS

Forty-nine Standardbred horses (age 11-33 months) presented for surgical removal of POF from 56 metatarsophalangeal joints. Synovial tissue collected at arthroscopy was subjected to histopathology. IL-1β, TNF-α, and PGE-2 were measured in synovial fluid using ELISA. Digital arthroscopy images were scored for inflammation. Racing performance data were retrieved from a public database.

RESULTS

Median time in race training prior to surgery was 8 weeks (IQR 4-12; range 0-40). There was minimal evidence of synovial inflammation as assessed by histopathology (median total score 2/20, IQR 0-2, range 0-5) or arthroscopy (median average total score 2.67/15, IQR 1.79-4, range 0-8.83). IL-1β was not detected in any sample. TNF-α (median 0 pg/mL, IQR 0-0) and PGE-2 (median 56.6 pg/mL, IRQ 40.5-99.8) were measured at low levels. Weeks in training prior to surgery was associated with the number of starts in the season after surgery (incidence rate ratio 1.02, 95% CI 1.00, 1.04, P = .03).

MAIN LIMITATIONS

Small sample size from a single breed with a relatively short training time prior to surgery.

CONCLUSIONS

There was minimal evidence of synovial inflammation in the metatarsophalangeal joints in this population of young Standardbred horses with POF. It is possible that POF may result in a different inflammatory response than other fragments because they are generally well-embedded in situ. These findings suggest that, in Standardbreds, race training can commence several weeks prior to surgical removal of POF with minimal detrimental effects on joint health, although further investigation of long-term effects of POF on joint health is warranted.

Influence of osteochondrosis on the longevity and racing performance of standardbred trotters and pacers

OBJECTIVE

To determine the influence of clinical osteochondrosis (OC) on the short-term (2, 3, and 4-year-old) and long-term racing performance and longevity of standardbred racehorses.

STUDY DESIGN

Retrospective case-control study.

SAMPLE POPULATION

Standardbred racehorses from a single breeding farm born between 2009 and 2017 that survived to racing age (n = 2711). Three hundred eighty-two (14%) horses were OC-affected (829 lesions confirmed arthroscopically during surgical treatment), and 2329 (86%) horses were nonaffected.

METHODS

Racing performance data were obtained from an online database and evaluated with multiple linear regression models.

RESULTS

Trotters were more likely than pacers to be affected by OC (odds ratio [OR] = 1.4, 95% CI = 1.1-1.9, P = .006). Compared with nonaffected horses, long-term OC-affected horses had 8.8 fewer starts (95% CI = -14.4 to -3.2, P = .002), 1.0 fewer wins (95% CI = -1.9 to -0.1, P = .030), and 3.8 fewer total number of first through third place finishes (95% CI = -6.2 to -1.4, P < .0001). Nonaffected horses had longer careers compared with OC-affected horses, racing 0.32 years longer (95% CI = -0.52 to -0.12, P = .002). Osteochondrosis had no impact on short-term racing performance. Horses with lesions at the distal intermediate ridge of the tibia or lateral trochlear ridge of the talus had decreased performance compared with horses without these lesions.

CONCLUSION

Pacers were less likely than trotters to be affected by OC. Affected horses had fewer starts and shorter careers, despite early surgical intervention.

CLINICAL SIGNIFICANCE

Osteochondrosis decreases long-term racing performance in racing standardbreds.

Identification and validation of risk loci for osteochondrosis in standardbreds

BACKGROUND

Osteochondrosis (OC), simply defined as a failure of endochondral ossification, is a complex disease with both genetic and environmental risk factors that is commonly diagnosed in young horses, as well as other domestic species. Although up to 50 % of the risk for developing OC is reportedly inherited, specific genes and alleles underlying risk are thus far completely unknown. Regions of the genome identified as associated with OC vary across studies in different populations of horses. In this study, we used a cohort of Standardbred horses from the U.S. (n = 182) specifically selected for a shared early environment (to reduce confounding factors) to identify regions of the genome associated with tarsal OC. Subsequently, putative risk variants within these regions were evaluated in both the discovery population and an independently sampled validation population of Norwegian Standardbreds (n = 139) with tarsal OC.

RESULTS

After genome-wide association analysis of imputed data with information from >200,000 single nucleotide polymorphisms, two regions on equine chromosome 14 were associated with OC in the discovery cohort. Variant discovery in these and 30 additional regions of interest (including 11 from other published studies) was performed via whole-genome sequencing. 240 putative risk variants from 10 chromosomes were subsequently genotyped in both the discovery and validation cohorts. After correction for population structure, gait (trot or pace) and sex, the variants most highly associated with OC status in both populations were located within the chromosome 14 regions of association.

CONCLUSIONS

The association of putative risk alleles from within the same regions with disease status in two independent populations of Standardbreds suggest that these are true risk loci in this breed, although population-specific risk factors may still exist. Evaluation of these loci in other populations will help determine if they are specific to the Standardbred breed, or to tarsal OC or are universal risk loci for OC. Further work is needed to identify the specific variants underlying OC risk within these loci. This is the first step towards the long-term goal of constructing a genetic risk model for OC that allows for genetic testing and quantification of risk in individuals.